Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2003
10/02/2003CA2478913A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003CA2477651A1 Kinase inhibitors
10/02/2003CA2476327A1 Method of administering an injectable antibiotic to the ear of an animal
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348443A1 Combination drugs
10/01/2003EP1348433A1 Thiazol-2-yl-imine compounds as PDE-7 inhibitors
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1348027A2 Gene disruption methodologies for drug target discovery
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347975A1 Novel purine derivatives, preparation method and use as medicines
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1347777A2 Immunogenic complex comprising ribosomes
10/01/2003EP1347776A2 Anti-inflammatory use of polycationic compounds
10/01/2003EP1347773A2 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
10/01/2003EP1347771A2 Methods of using imxp-888 and imxp-888 antagonists
10/01/2003EP1347768A1 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa
10/01/2003EP1347761A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/01/2003EP1347759A1 Antibacterial compounds
10/01/2003EP1347758A1 Azole compounds as anti-fungals agents
10/01/2003EP1347747A2 Method for preparing submicron particle suspensions
10/01/2003EP1347746A1 Over-coated chewing gum formulations including tableted center
10/01/2003EP1218339B1 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides
10/01/2003EP1202954B1 Novel aminobenzophenones
10/01/2003EP1051190B1 Vaccine compositions for mucosal administration comprising chitosan and influenza antigen(s)
10/01/2003EP1000029B1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
10/01/2003EP0999854B1 Switchable viscoelastic systems containing galactomannan polymers and borate
10/01/2003EP0988310B1 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
10/01/2003EP0772596B1 INDOLIZINE sPLA2 INHIBITORS
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446265A Means and method for monitoring antiretroviral therapy and guiding therapeutic decisions in treatment of HIV/AIDS
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446213A Medicinal compositions containing propenone derivatives
10/01/2003CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/01/2003CN1446103A Treating endotoxemia and related disorders with probiotics
10/01/2003CN1446102A Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
10/01/2003CN1446101A Combination product comprising melagatran and factor VLLa inhibitor
10/01/2003CN1446095A Animal papilla disinfectants and method for improving microbial environment which harmful to animal
10/01/2003CN1446094A Method for obtaining antigenic structures enhancing specific cross reactivity
10/01/2003CN1446092A Aqueous pharmaceutical compositions
10/01/2003CN1446082A ÔÇ£Slow releaseÔÇØ pharmaceutical compositions comprising lithium carbonate
10/01/2003CN1446080A Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
10/01/2003CN1445240A Killer cell antibiosis polypeptide activated by lymphokine and its application
10/01/2003CN1444995A Method for filtering out matters possible to restrain and/or activate target biological activity in a iming at phenomena of spatial allosterism of the target
10/01/2003CN1444993A Application of the recombination human interferon omega in preparing medicine for preventing and treating not typical model pneumonia
10/01/2003CN1444989A Application of eupatorium for preparing medicine to prevent and treat serious acute respiratory syndrome (SARS)
10/01/2003CN1444962A Medicine for treating bone tuberculosis
10/01/2003CN1444959A Chinese herbal medicine for birds and beasts use and its preparing method
10/01/2003CN1444955A Chinese herbal medicine for treating hepatitis
10/01/2003CN1444938A Metronidazole, Clotrimazole and Chlorhexidime Acetate preparation and its preparing method
10/01/2003CN1444937A Drop pills of andrographolide and its preparing method
10/01/2003CN1444936A Drop pills of ÔÇÿWurenchunÔÇÖ and its preparing method
10/01/2003CN1444929A Fibrauretine dispersant tablet and its preparing method
10/01/2003CN1444928A Drop pills of five esters and its preparing method
10/01/2003CN1444926A Bio-adhesiveness drug release system
10/01/2003CN1444922A Application of biologically active substance-fenugreek ketone and its derivatives
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
10/01/2003CN1122510C Medicinal composition for treating AIDS and its application
10/01/2003CN1122443C Antiparasitic composition for treating and protecting pets
09/2003
09/30/2003US6627747 Essential bacterial genes and their use
09/30/2003US6627743 6-O-methylerythromycin A crystal form III
09/30/2003US6627730 Of given amino acid sequence, and diagnostic test kit; multidrug resistance
09/30/2003US6627664 Administering perylenequinone derivative, and activating the derivative by exposing the perylenequinone to sound of a pre-determined frequency for therapy
09/30/2003US6627651 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human
09/30/2003US6627640 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
09/30/2003US6627638 Viricides, anticarcinogneic agents
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627629 Useful for the treatment or prevention of asthma and other allergic diseases.
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627615 Methods and compositions for in vivo gene therapy
09/30/2003US6627604 Memno peptides, process for their preparation and use thereof
09/30/2003US6627224 Low dose entecavir formulation and use
09/30/2003US6627215 Devices for improved wound management
09/30/2003US6627204 Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses
09/30/2003US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
09/30/2003US6627195 Binding agents to CD23
09/30/2003CA2393614C Antibacterial clarithromycin compositions and processes for making the same
09/30/2003CA2133759C Evaluation and treatment of patients with progressive immunosuppression
09/25/2003WO2003080572A1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078609A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078608A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078455A2 Virus like particle from papillomavirus and their use in vaccine
09/25/2003WO2003078453A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003WO2003078440A1 Broad-spectrum cephem compounds
09/25/2003WO2003078439A1 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003078435A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
09/25/2003WO2003078431A1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
09/25/2003WO2003078427A1 Azolylaminoazines as inhibitors of protein kinases
09/25/2003WO2003078426A1 Azolylaminoazine as inhibitors of protein kinases
09/25/2003WO2003078421A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078413A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003078395A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078367A2 Benzyl alcohol derivatives and their use as antimicrobial agents
1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 1798